 Kathryn Collins
Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryosurgery | 14 | 2018 | 47 | 3.630 |
Why?
| | Heart Defects, Congenital | 27 | 2022 | 914 | 3.540 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 13 | 2012 | 28 | 2.990 |
Why?
| | Tachycardia, Ventricular | 12 | 2023 | 181 | 2.860 |
Why?
| | Pacemaker, Artificial | 9 | 2024 | 126 | 2.550 |
Why?
| | Electrophysiologic Techniques, Cardiac | 22 | 2019 | 84 | 2.250 |
Why?
| | Catheter Ablation | 23 | 2022 | 353 | 2.250 |
Why?
| | Heart Conduction System | 9 | 2020 | 95 | 2.050 |
Why?
| | Wolff-Parkinson-White Syndrome | 11 | 2020 | 19 | 2.020 |
Why?
| | Defibrillators, Implantable | 11 | 2024 | 382 | 1.810 |
Why?
| | Arrhythmias, Cardiac | 15 | 2020 | 361 | 1.650 |
Why?
| | Electrocardiography | 21 | 2023 | 662 | 1.610 |
Why?
| | Tachycardia, Supraventricular | 8 | 2022 | 45 | 1.440 |
Why?
| | Device Removal | 3 | 2021 | 143 | 1.290 |
Why?
| | Cardiac Pacing, Artificial | 7 | 2017 | 84 | 1.150 |
Why?
| | Ventricular Premature Complexes | 2 | 2022 | 37 | 1.050 |
Why?
| | Heart Rate | 6 | 2019 | 855 | 1.000 |
Why?
| | Electrodes, Implanted | 4 | 2024 | 115 | 0.860 |
Why?
| | Echocardiography, Three-Dimensional | 2 | 2024 | 71 | 0.830 |
Why?
| | Cicatrix | 2 | 2018 | 69 | 0.830 |
Why?
| | Echocardiography, Transesophageal | 2 | 2024 | 133 | 0.830 |
Why?
| | Child | 54 | 2023 | 22633 | 0.730 |
Why?
| | Adolescent | 47 | 2023 | 22428 | 0.720 |
Why?
| | Pediatrics | 6 | 2020 | 1114 | 0.720 |
Why?
| | Death, Sudden, Cardiac | 8 | 2020 | 230 | 0.710 |
Why?
| | Retrospective Studies | 46 | 2023 | 17066 | 0.660 |
Why?
| | Treatment Outcome | 36 | 2022 | 11679 | 0.650 |
Why?
| | Cardiac Surgical Procedures | 6 | 2018 | 609 | 0.630 |
Why?
| | Risk Assessment | 9 | 2020 | 3671 | 0.630 |
Why?
| | Electric Countershock | 6 | 2015 | 127 | 0.620 |
Why?
| | Long QT Syndrome | 3 | 2014 | 69 | 0.590 |
Why?
| | Tachycardia | 6 | 2016 | 57 | 0.580 |
Why?
| | Esthetics | 1 | 2018 | 41 | 0.570 |
Why?
| | Fontan Procedure | 4 | 2012 | 191 | 0.560 |
Why?
| | Heart Atria | 3 | 2017 | 144 | 0.550 |
Why?
| | Equipment Failure | 3 | 2013 | 115 | 0.550 |
Why?
| | Heart Valve Diseases | 2 | 2020 | 151 | 0.520 |
Why?
| | Prosthesis Implantation | 3 | 2024 | 153 | 0.520 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 128 | 0.500 |
Why?
| | Female | 65 | 2024 | 78271 | 0.500 |
Why?
| | Humans | 96 | 2024 | 144759 | 0.500 |
Why?
| | Tetralogy of Fallot | 5 | 2018 | 76 | 0.480 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2017 | 197 | 0.480 |
Why?
| | Anti-Arrhythmia Agents | 8 | 2021 | 142 | 0.470 |
Why?
| | Pre-Excitation Syndromes | 1 | 2015 | 5 | 0.470 |
Why?
| | Anesthesia | 1 | 2019 | 258 | 0.460 |
Why?
| | Male | 62 | 2024 | 72315 | 0.450 |
Why?
| | Heart Block | 4 | 2008 | 40 | 0.440 |
Why?
| | Transposition of Great Vessels | 3 | 2013 | 41 | 0.440 |
Why?
| | Follow-Up Studies | 16 | 2020 | 5408 | 0.430 |
Why?
| | Atrial Flutter | 4 | 2017 | 45 | 0.410 |
Why?
| | Mitral Valve | 1 | 2014 | 96 | 0.400 |
Why?
| | Axilla | 2 | 2010 | 51 | 0.380 |
Why?
| | Foreign Bodies | 1 | 2013 | 107 | 0.370 |
Why?
| | Aortic Valve | 2 | 2020 | 365 | 0.370 |
Why?
| | Cardiology | 3 | 2014 | 353 | 0.360 |
Why?
| | Atrial Fibrillation | 4 | 2018 | 550 | 0.360 |
Why?
| | Recurrence | 8 | 2019 | 1135 | 0.350 |
Why?
| | Heart Ventricles | 4 | 2009 | 760 | 0.330 |
Why?
| | Atrioventricular Node | 2 | 2010 | 15 | 0.330 |
Why?
| | Defibrillators | 1 | 2010 | 23 | 0.330 |
Why?
| | Tachycardia, Reciprocating | 3 | 2017 | 5 | 0.310 |
Why?
| | Fetal Diseases | 2 | 2012 | 191 | 0.310 |
Why?
| | Child, Preschool | 23 | 2020 | 11787 | 0.310 |
Why?
| | Cosmetic Techniques | 1 | 2009 | 13 | 0.300 |
Why?
| | Calsequestrin | 2 | 2020 | 8 | 0.300 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2010 | 46 | 0.300 |
Why?
| | Atrioventricular Block | 4 | 2011 | 45 | 0.300 |
Why?
| | Tachycardia, Ectopic Junctional | 1 | 2009 | 4 | 0.300 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2010 | 59 | 0.300 |
Why?
| | Domperidone | 1 | 2008 | 1 | 0.290 |
Why?
| | Cardiac Electrophysiology | 2 | 2020 | 21 | 0.280 |
Why?
| | Quality of Life | 2 | 2018 | 3185 | 0.280 |
Why?
| | Magnetocardiography | 1 | 2008 | 2 | 0.270 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2022 | 392 | 0.260 |
Why?
| | Pulmonary Valve | 3 | 2018 | 101 | 0.260 |
Why?
| | Coronary Vessel Anomalies | 1 | 2007 | 38 | 0.250 |
Why?
| | Infant | 19 | 2020 | 10034 | 0.240 |
Why?
| | Young Adult | 14 | 2021 | 14105 | 0.230 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2021 | 64 | 0.230 |
Why?
| | Adult | 30 | 2021 | 40449 | 0.220 |
Why?
| | Accessory Atrioventricular Bundle | 3 | 2015 | 13 | 0.220 |
Why?
| | Decision Making | 1 | 2011 | 975 | 0.200 |
Why?
| | Societies, Medical | 4 | 2016 | 887 | 0.200 |
Why?
| | Echocardiography | 4 | 2016 | 652 | 0.200 |
Why?
| | Bundle of His | 4 | 2010 | 19 | 0.200 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2018 | 248 | 0.190 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 120 | 0.190 |
Why?
| | Syncope | 1 | 2023 | 55 | 0.190 |
Why?
| | Catheters | 1 | 2022 | 75 | 0.180 |
Why?
| | Infant, Newborn | 11 | 2020 | 6429 | 0.180 |
Why?
| | Time Factors | 10 | 2019 | 7173 | 0.180 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1356 | 0.170 |
Why?
| | Risk Factors | 13 | 2020 | 10779 | 0.170 |
Why?
| | Sensitivity and Specificity | 5 | 2015 | 1985 | 0.160 |
Why?
| | Electrophysiology | 2 | 2016 | 218 | 0.160 |
Why?
| | Cardiomyopathies | 3 | 2014 | 338 | 0.160 |
Why?
| | Fetal Heart | 1 | 2021 | 57 | 0.160 |
Why?
| | Registries | 5 | 2018 | 2385 | 0.160 |
Why?
| | Heart Transplantation | 2 | 2003 | 736 | 0.160 |
Why?
| | Child of Impaired Parents | 1 | 2020 | 38 | 0.160 |
Why?
| | Homozygote | 1 | 2020 | 199 | 0.160 |
Why?
| | California | 2 | 2013 | 475 | 0.150 |
Why?
| | Heterozygote | 1 | 2020 | 315 | 0.150 |
Why?
| | Prevalence | 3 | 2015 | 2834 | 0.150 |
Why?
| | Colorado | 4 | 2019 | 4564 | 0.140 |
Why?
| | Interprofessional Relations | 2 | 2020 | 281 | 0.140 |
Why?
| | Preoperative Care | 3 | 2018 | 379 | 0.140 |
Why?
| | International Cooperation | 2 | 2016 | 198 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 340 | 0.140 |
Why?
| | Naloxone | 1 | 2019 | 132 | 0.140 |
Why?
| | Death, Sudden | 1 | 2017 | 24 | 0.130 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 72 | 0.130 |
Why?
| | Cardiac Catheterization | 2 | 2013 | 560 | 0.130 |
Why?
| | Parent-Child Relations | 1 | 2020 | 270 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2020 | 253 | 0.130 |
Why?
| | Survival Rate | 3 | 2020 | 2089 | 0.130 |
Why?
| | Heart Arrest | 2 | 2020 | 407 | 0.120 |
Why?
| | Pharmacists | 1 | 2019 | 240 | 0.120 |
Why?
| | Education, Medical | 1 | 2020 | 274 | 0.120 |
Why?
| | Exercise Test | 3 | 2020 | 634 | 0.120 |
Why?
| | Prognosis | 3 | 2018 | 4282 | 0.120 |
Why?
| | Patient Selection | 3 | 2015 | 719 | 0.120 |
Why?
| | Buprenorphine | 1 | 2019 | 190 | 0.120 |
Why?
| | Stroke Volume | 2 | 2016 | 651 | 0.110 |
Why?
| | Attitude of Health Personnel | 3 | 2020 | 1185 | 0.110 |
Why?
| | Sympathectomy | 1 | 2015 | 7 | 0.110 |
Why?
| | Vectorcardiography | 1 | 2014 | 4 | 0.110 |
Why?
| | Prospective Studies | 5 | 2018 | 7990 | 0.110 |
Why?
| | Causality | 1 | 2015 | 126 | 0.110 |
Why?
| | Students, Medical | 1 | 2020 | 375 | 0.110 |
Why?
| | Drug Overdose | 1 | 2019 | 370 | 0.110 |
Why?
| | Age Factors | 6 | 2016 | 3333 | 0.110 |
Why?
| | Age Distribution | 1 | 2015 | 403 | 0.110 |
Why?
| | Sex Distribution | 1 | 2015 | 386 | 0.110 |
Why?
| | Cardiography, Impedance | 1 | 2014 | 9 | 0.110 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 541 | 0.100 |
Why?
| | Shock, Cardiogenic | 1 | 2014 | 64 | 0.100 |
Why?
| | Middle Aged | 15 | 2024 | 35875 | 0.100 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2013 | 18 | 0.100 |
Why?
| | Endocardium | 1 | 2013 | 31 | 0.100 |
Why?
| | Milrinone | 1 | 2013 | 26 | 0.100 |
Why?
| | Predictive Value of Tests | 5 | 2014 | 2115 | 0.100 |
Why?
| | Norwood Procedures | 1 | 2013 | 29 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2014 | 118 | 0.100 |
Why?
| | Health Personnel | 1 | 2020 | 748 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 359 | 0.100 |
Why?
| | Hepatic Veins | 1 | 2013 | 32 | 0.100 |
Why?
| | Curriculum | 1 | 2020 | 1059 | 0.090 |
Why?
| | Risk | 2 | 2020 | 911 | 0.090 |
Why?
| | Sotalol | 1 | 2012 | 13 | 0.090 |
Why?
| | Calcium Channel Blockers | 1 | 2013 | 165 | 0.090 |
Why?
| | Perioperative Care | 1 | 2014 | 231 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 340 | 0.090 |
Why?
| | Consensus | 1 | 2014 | 488 | 0.090 |
Why?
| | Syncope, Vasovagal | 1 | 2011 | 6 | 0.090 |
Why?
| | Comorbidity | 2 | 2015 | 1658 | 0.090 |
Why?
| | Fluoroscopy | 3 | 2024 | 176 | 0.090 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 61 | 0.090 |
Why?
| | Coronary Angiography | 1 | 2013 | 323 | 0.090 |
Why?
| | Heart Failure | 2 | 2016 | 2323 | 0.090 |
Why?
| | Cineangiography | 1 | 2011 | 9 | 0.090 |
Why?
| | Parents | 1 | 2020 | 1403 | 0.080 |
Why?
| | United States | 6 | 2019 | 15966 | 0.080 |
Why?
| | Adenosine | 1 | 2013 | 255 | 0.080 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 600 | 0.080 |
Why?
| | Incidence | 3 | 2020 | 2879 | 0.080 |
Why?
| | Patient Safety | 1 | 2014 | 347 | 0.080 |
Why?
| | Algorithms | 2 | 2020 | 1837 | 0.080 |
Why?
| | Contraindications | 1 | 2010 | 91 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2020 | 1094 | 0.080 |
Why?
| | Clavicle | 1 | 2010 | 38 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3409 | 0.080 |
Why?
| | ROC Curve | 2 | 2016 | 614 | 0.080 |
Why?
| | Atrial Appendage | 1 | 2010 | 35 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2016 | 276 | 0.080 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2014 | 383 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 539 | 0.080 |
Why?
| | Subclavian Vein | 1 | 2009 | 15 | 0.080 |
Why?
| | Logistic Models | 4 | 2017 | 2117 | 0.080 |
Why?
| | Sinoatrial Node | 1 | 2009 | 27 | 0.070 |
Why?
| | Chronic Disease | 1 | 2015 | 1813 | 0.070 |
Why?
| | Postoperative Complications | 3 | 2014 | 2919 | 0.070 |
Why?
| | Cisapride | 1 | 2008 | 5 | 0.070 |
Why?
| | Bacteremia | 1 | 2011 | 221 | 0.070 |
Why?
| | Dopamine Antagonists | 1 | 2008 | 25 | 0.070 |
Why?
| | Torsades de Pointes | 1 | 2008 | 23 | 0.070 |
Why?
| | Health Surveys | 1 | 2010 | 518 | 0.070 |
Why?
| | Carotid Artery Injuries | 1 | 2008 | 39 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 6048 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2014 | 567 | 0.070 |
Why?
| | Heart Rate, Fetal | 1 | 2008 | 31 | 0.070 |
Why?
| | Quality Improvement | 2 | 2014 | 1289 | 0.070 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1539 | 0.070 |
Why?
| | Myocarditis | 1 | 2008 | 102 | 0.060 |
Why?
| | Carotid Arteries | 1 | 2008 | 207 | 0.060 |
Why?
| | Myocardial Contraction | 1 | 2008 | 298 | 0.060 |
Why?
| | Drug Hypersensitivity | 1 | 2008 | 90 | 0.060 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2008 | 145 | 0.060 |
Why?
| | Heart Diseases | 1 | 2010 | 349 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5868 | 0.060 |
Why?
| | Body Weight | 1 | 2011 | 976 | 0.060 |
Why?
| | Chronic Pain | 1 | 2011 | 290 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2024 | 3604 | 0.060 |
Why?
| | Mutation | 1 | 2018 | 4089 | 0.060 |
Why?
| | Atrial Function | 1 | 2006 | 10 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 1980 | 0.060 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 257 | 0.060 |
Why?
| | Gastroesophageal Reflux | 1 | 2008 | 236 | 0.060 |
Why?
| | Prenatal Diagnosis | 1 | 2008 | 195 | 0.060 |
Why?
| | Family Therapy | 1 | 2006 | 67 | 0.060 |
Why?
| | Myocardial Ischemia | 1 | 2006 | 285 | 0.050 |
Why?
| | Physician's Role | 1 | 2006 | 218 | 0.050 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 221 | 0.050 |
Why?
| | Pregnancy | 3 | 2021 | 7190 | 0.050 |
Why?
| | Heart Septum | 1 | 2004 | 28 | 0.050 |
Why?
| | Canada | 2 | 2016 | 428 | 0.050 |
Why?
| | Neural Conduction | 1 | 2004 | 92 | 0.050 |
Why?
| | Focus Groups | 1 | 2006 | 573 | 0.050 |
Why?
| | Bundle-Branch Block | 1 | 2003 | 36 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 732 | 0.050 |
Why?
| | Ebstein Anomaly | 1 | 2002 | 7 | 0.050 |
Why?
| | Tachycardia, Paroxysmal | 1 | 2002 | 8 | 0.050 |
Why?
| | Diastole | 1 | 2022 | 143 | 0.040 |
Why?
| | Genotype | 1 | 2006 | 1833 | 0.040 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 197 | 0.040 |
Why?
| | Fetal Monitoring | 1 | 2021 | 20 | 0.040 |
Why?
| | Aged | 6 | 2024 | 25913 | 0.040 |
Why?
| | Child Abuse | 1 | 2006 | 551 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 540 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 138 | 0.040 |
Why?
| | Seasons | 1 | 2002 | 556 | 0.040 |
Why?
| | Philadelphia | 1 | 2019 | 55 | 0.040 |
Why?
| | Exercise | 1 | 2011 | 2201 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2020 | 147 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2452 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2004 | 2029 | 0.040 |
Why?
| | Heredity | 1 | 2018 | 12 | 0.030 |
Why?
| | Phenotype | 2 | 2018 | 3162 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2002 | 514 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 583 | 0.030 |
Why?
| | Gestational Age | 1 | 2021 | 975 | 0.030 |
Why?
| | Survival Analysis | 1 | 2000 | 1382 | 0.030 |
Why?
| | Genetic Markers | 1 | 2018 | 331 | 0.030 |
Why?
| | Perioperative Period | 1 | 2017 | 71 | 0.030 |
Why?
| | Global Health | 1 | 2020 | 401 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 406 | 0.030 |
Why?
| | Pedigree | 1 | 2018 | 514 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 570 | 0.030 |
Why?
| | Reoperation | 1 | 2019 | 630 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2016 | 95 | 0.030 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2016 | 48 | 0.030 |
Why?
| | Action Potentials | 1 | 2019 | 506 | 0.030 |
Why?
| | Animals | 2 | 2008 | 38058 | 0.030 |
Why?
| | Protein Conformation | 1 | 2018 | 946 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2016 | 221 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 251 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1075 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1486 | 0.030 |
Why?
| | Needs Assessment | 1 | 2016 | 404 | 0.020 |
Why?
| | Phlebography | 1 | 2013 | 39 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2013 | 84 | 0.020 |
Why?
| | Models, Molecular | 1 | 2018 | 1618 | 0.020 |
Why?
| | Sick Sinus Syndrome | 1 | 2012 | 1 | 0.020 |
Why?
| | Hydrops Fetalis | 1 | 2012 | 13 | 0.020 |
Why?
| | Electrodiagnosis | 1 | 2012 | 17 | 0.020 |
Why?
| | Digoxin | 1 | 2012 | 27 | 0.020 |
Why?
| | Fetal Death | 1 | 2012 | 58 | 0.020 |
Why?
| | Boston | 1 | 2012 | 92 | 0.020 |
Why?
| | Live Birth | 1 | 2012 | 68 | 0.020 |
Why?
| | Benchmarking | 1 | 2013 | 188 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2013 | 331 | 0.020 |
Why?
| | Bradycardia | 1 | 2012 | 59 | 0.020 |
Why?
| | Radiography, Interventional | 1 | 2013 | 130 | 0.020 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 297 | 0.020 |
Why?
| | Ultrasonography, Interventional | 1 | 2013 | 160 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 529 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.020 |
Why?
| | Signal Transduction | 1 | 2004 | 5226 | 0.020 |
Why?
| | Dissection | 1 | 2010 | 56 | 0.020 |
Why?
| | Abortion, Induced | 1 | 2012 | 110 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2027 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2363 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 1095 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1047 | 0.020 |
Why?
| | Seat Belts | 1 | 2008 | 23 | 0.020 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2008 | 16 | 0.020 |
Why?
| | Hematoma | 1 | 2008 | 59 | 0.020 |
Why?
| | Premature Birth | 1 | 2012 | 380 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1462 | 0.020 |
Why?
| | Length of Stay | 1 | 2013 | 1337 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2008 | 190 | 0.020 |
Why?
| | Oxygenators | 1 | 2006 | 4 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2925 | 0.020 |
Why?
| | Manuals as Topic | 1 | 2006 | 16 | 0.020 |
Why?
| | Radiography | 1 | 2008 | 844 | 0.010 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2008 | 228 | 0.010 |
Why?
| | Otitis Media | 1 | 2008 | 181 | 0.010 |
Why?
| | Wounds, Nonpenetrating | 1 | 2008 | 316 | 0.010 |
Why?
| | Biopsy | 1 | 2008 | 1075 | 0.010 |
Why?
| | Ultrasonography | 1 | 2008 | 770 | 0.010 |
Why?
| | Job Satisfaction | 1 | 2006 | 240 | 0.010 |
Why?
| | Body Size | 1 | 2004 | 95 | 0.010 |
Why?
| | Body Surface Potential Mapping | 1 | 2002 | 8 | 0.010 |
Why?
| | Equipment Design | 1 | 2004 | 530 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2730 | 0.010 |
Why?
| | Social Support | 1 | 2006 | 652 | 0.010 |
Why?
| | North America | 1 | 2002 | 310 | 0.010 |
Why?
| | Professional-Family Relations | 1 | 2003 | 153 | 0.010 |
Why?
| | Observer Variation | 1 | 2002 | 355 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2008 | 741 | 0.010 |
Why?
| | Child Welfare | 1 | 2002 | 231 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2002 | 1306 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1907 | 0.010 |
Why?
| | Communication | 1 | 2003 | 965 | 0.010 |
Why?
| | Cohort Studies | 1 | 2002 | 5960 | 0.010 |
Why?
|
|
Collins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|